AABB launched a new website to inform the public, blood collectors and clinicians about COVID-19 convalescent plasma. The website provides information to connect people who have recovered from COVID-19 to AABB-accredited blood centers so that they can potentially donate convalescent plasma to help improve the status of critically ill patients with COVID-19. AABB yesterday also sent a letter to its member hospitals encouraging them to collaborate with their blood supplier by identifying and referring individuals who have recovered from COVID-19 for donation of COVID-19 convalescent plasma. The Food and Drug Administration, which considers COVID-19 convalescent plasma an investigational treatment, recently announced new guidelines permitting its use for patients with moderate or severe COVID-19 infections.

Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…